- Home
- IMSR vs TNYA Comparison
IMSR vs TNYA Comparison
Compare IMSR & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMSR
- TNYA
- Stock Information
- Founded
- IMSR 2013
- TNYA 2016
- Country
- IMSR United States
- TNYA United States
- Employees
- IMSR N/A
- TNYA 97
- Industry
- IMSR
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- IMSR
- TNYA Health Care
- Exchange
- IMSR Nasdaq
- TNYA Nasdaq
- Market Cap
- IMSR 233.8M
- TNYA 204.8M
- IPO Year
- IMSR N/A
- TNYA 2021
- Fundamental
- Price
- IMSR $8.09
- TNYA $1.24
- Analyst Decision
- IMSR
- TNYA Strong Buy
- Analyst Count
- IMSR 0
- TNYA 5
- Target Price
- IMSR N/A
- TNYA $8.60
- AVG Volume (30 Days)
- IMSR 1.8M
- TNYA 3.6M
- Earning Date
- IMSR 01-01-0001
- TNYA 11-10-2025
- Dividend Yield
- IMSR N/A
- TNYA N/A
- EPS Growth
- IMSR N/A
- TNYA N/A
- EPS
- IMSR N/A
- TNYA N/A
- Revenue
- IMSR $123,320.00
- TNYA N/A
- Revenue This Year
- IMSR N/A
- TNYA N/A
- Revenue Next Year
- IMSR N/A
- TNYA N/A
- P/E Ratio
- IMSR N/A
- TNYA N/A
- Revenue Growth
- IMSR 1234.25
- TNYA N/A
- 52 Week Low
- IMSR $8.65
- TNYA $0.36
- 52 Week High
- IMSR $31.50
- TNYA $4.01
- Technical
- Relative Strength Index (RSI)
- IMSR N/A
- TNYA 41.17
- Support Level
- IMSR N/A
- TNYA $1.15
- Resistance Level
- IMSR N/A
- TNYA $1.28
- Average True Range (ATR)
- IMSR 0.00
- TNYA 0.12
- MACD
- IMSR 0.00
- TNYA -0.01
- Stochastic Oscillator
- IMSR 0.00
- TNYA 20.73
About IMSR Terrestrial Energy Inc. Common Stock
Terrestrial Energy Inc is an industry-leading technology company committed to delivering reliable, emission-free, and cost-competitive nuclear energy with a transformative advanced reactor, the Integral Molten Salt Reactor (IMSR). Its mission is to transform global energy markets by commercializing its IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.